Literature DB >> 21462243

How does neuromodulation work.

Bastian Amend1, Klaus E Matzel, Paul Abrams, William C de Groat, Karl-Dietrich Sievert.   

Abstract

Although sacral neuromodulation (SNM) is approved and successfully used for different urological and proctologic functional diseases for the long-term treatment, less is known about the working mechanisms underlying SNM. This review highlights SNM clinical application, the current data of LUT neuroanatomy and neurophysiology, SNM techniques and its prospective working mechanisms. Functional imaging techniques have facilitated a more detailed insight into the neural network between the central nervous system (CNS) and the lower urinary tract (LUT). In addition to the well-known factors of the spinal micturition pathway, several pontine (e.g. pontine micturition centre) and suprapontine (e.g. cingulate cortex) regions and their interactions have been identified. An attribution of CNS activity levels to different LUT conditions is possible for the first time. Based on this information, different SNM actions could also have been allocated to different ascending/descending pathways and supraspinal regions, whereas acute SNM especially affects regions of learning activity, chronic SNM might result in CNS plasticity even though clinical effectiveness fades after SNM deactivation. Studies to treat fecal incontinence or to prevent detrusor overactivity in complete spinal cord injured patients support the importance of sympathetic pathways for the action of SNM. Despite increasing knowledge about SNM influence on the CNS, the complexity of its underlying working mechanisms is not understood at all. Further investigations with improved functional imaging techniques will enhance our SNM background.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21462243     DOI: 10.1002/nau.21096

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  9 in total

Review 1.  How does sacral modulation work best? Placement and programming techniques to maximize efficacy.

Authors:  Bastian Amend; Mahmoud Khalil; Thomas M Kessler; Karl-Dietrich Sievert
Journal:  Curr Urol Rep       Date:  2011-10       Impact factor: 3.092

Review 2.  Electrical neuromodulation in the management of lower urinary tract dysfunction: evidence, experience and future prospects.

Authors:  Alejandro Abello; Anurag K Das
Journal:  Ther Adv Urol       Date:  2018-02-22

3.  Effects of percutaneous neuromodulation in neuromusculoskeletal pathologies: A systematic review.

Authors:  Ibon Fidalgo-Martin; Juan José Ramos-Álvarez; Roberto Murias-Lozano; Elena Sonsoles Rodríguez-López
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

4.  An Intermediate Animal Model of Spinal Cord Stimulation.

Authors:  Thomas Guiho; Christine Azevedo Coste; Claire Delleci; Jean-Patrick Chenu; Jean-Rodolphe Vignes; Luc Bauchet; David Guiraud
Journal:  Eur J Transl Myol       Date:  2016-06-13

5.  Functional segregation within the pelvic nerve of male rats: a meso- and microscopic analysis.

Authors:  Martin M Bertrand; Nadja Korajkic; Peregrine B Osborne; Janet R Keast
Journal:  J Anat       Date:  2020-06-29       Impact factor: 2.610

6.  Refractory Sexual Arousal Subsequent to Sacral Neuromodulation.

Authors:  Dani Zoorob; Amanda S Deis; Kathryn Lindsay
Journal:  Case Rep Obstet Gynecol       Date:  2019-04-02

7.  Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation.

Authors:  Hamilton Trinh; Vicki Irish; Mireya Diaz; Humphrey Atiemo
Journal:  Int Neurourol J       Date:  2019-09-30       Impact factor: 2.835

8.  Noninvasive spinal neuromodulation mitigates symptoms of idiopathic overactive bladder.

Authors:  Hui Zhong; Emilie Liu; Priya Kohli; Laura Perez; V Reggie Edgerton; David Ginsberg; Parag Gad; Evgeniy Kreydin
Journal:  Bioelectron Med       Date:  2022-03-23

9.  Kegel Exercises, Biofeedback, Electrostimulation, and Peripheral Neuromodulation Improve Clinical Symptoms of Fecal Incontinence and Affect Specific Physiological Targets: An Randomized Controlled Trial.

Authors:  Lluís Mundet; Laia Rofes; Omar Ortega; Christopher Cabib; Pere Clavé
Journal:  J Neurogastroenterol Motil       Date:  2021-01-30       Impact factor: 4.924

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.